Trial Profile
A Study to Evaluate the Effect of Fingolimod on Newly Produced T and B Lymphocytes and T-Cell Receptor Repertoire Diversity in Peripheral Blood in Patients With Multiple Sclerosis (MS)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Feb 2016
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- 26 Feb 2016 New trial record